Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Checkpoint blockade has formally demonstrated that reactivating anti-tumor immune responses can regress tumors. However, this only occurs in a fraction of patients. Incorporating these therapies in more powerful combinations is thus a logical next step. Here, we review functional roles of immune che...

Full description

Bibliographic Details

Published in:	Cancer cell Vol. 33; no. 4; p. 581
Main Authors:	Zappasodi, Roberta, Merghoub, Taha, Wolchok, Jedd D
Format:	Journal Article
Language:	English
Published:	United States 09.04.2018
Subjects:	Antibodies, Blocking - therapeutic use B7-H1 Antigen - immunology Clinical Trials as Topic Combined Modality Therapy - methods CTLA-4 Antigen - immunology Humans Immunotherapy - methods Neoplasms - immunology Neoplasms - therapy Programmed Cell Death 1 Receptor - immunology Tumor Burden - drug effects tumor immunology immunotherapy-based combinations cancer immunotherapy immune checkpoint blockade
ISSN:	1878-3686, 1878-3686
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!